Literature DB >> 31782764

OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine.

Dirk Dressler1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31782764     DOI: 10.1093/brain/awz366

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  1 in total

1.  Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine.

Authors:  Judith A Pijpers; Michel D Ferrari; Gisela M Terwindt
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.